BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11137827)

  • 1. Low-grade exercise enhances platelet aggregability in patients with obstructive coronary disease independently of myocardial ischemia.
    Andreotti F; Lanza GA; Sciahbasi A; Fischetti D; Sestito A; De Cristofaro R; Maseri A
    Am J Cardiol; 2001 Jan; 87(1):16-20. PubMed ID: 11137827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticlopidine and aspirin fail to suppress the increased platelet aggregability that follows percutaneous coronary interventions.
    Fischetti D; Sciahbasi A; Leone AM; Niccoli G; Schiavoni G; Trani C; Mazzari MA; Andreotti F
    J Thromb Thrombolysis; 2000 Dec; 10(3):265-9. PubMed ID: 11122547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregability in cardiac syndrome X.
    Lanza GA; Andreotti F; Sestito A; Sciahbasi A; Crea F; Maseri A
    Eur Heart J; 2001 Oct; 22(20):1924-30. PubMed ID: 11601836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.
    Onoda K; Ohashi K; Hashimoto A; Okuda M; Shimono T; Nishikawa M; Shimpo H
    Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):230-7. PubMed ID: 18818572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention.
    Tanigawa T; Nishikawa M; Kitai T; Ueda Y; Okinaka T; Makino K; Ito M; Isaka N; Ikeda Y; Shiku H; Nakano T
    Am J Cardiol; 2000 May; 85(9):1054-9. PubMed ID: 10781751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation is dependent on platelet count in patients with coronary artery disease.
    Würtz M; Hvas AM; Kristensen SD; Grove EL
    Thromb Res; 2012 Jan; 129(1):56-61. PubMed ID: 21917303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor.
    Hansson EC; Shams Hakimi C; Åström-Olsson K; Hesse C; Wallén H; Dellborg M; Albertsson P; Jeppsson A
    Br J Anaesth; 2014 Mar; 112(3):570-5. PubMed ID: 24148324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes.
    Eikelboom JW; Weitz JI; Budaj A; Zhao F; Copland I; Maciejewski P; Johnston M; Yusuf S
    Eur Heart J; 2002 Nov; 23(22):1771-9. PubMed ID: 12419297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation and P-selectin levels during exercise treadmill test in patients with ischaemic heart disease.
    Kobusiak-Prokopowicz M; Kuliczkowski W; Karolko B; Prajs I; Mazurek W
    Kardiol Pol; 2006 Oct; 64(10):1094-100; discussion 1101. PubMed ID: 17089241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
    Arzamendi D; Dandachli F; Théorêt JF; Ducrocq G; Chan M; Mourad W; Gilbert JC; Schaub RG; Tanguay JF; Merhi Y
    Clin Appl Thromb Hemost; 2011; 17(6):E70-8. PubMed ID: 21078615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High shear stress induced platelet aggregation (h-SIPA) and effects of antiplatelet therapy].
    Isaka N; Tanigawa T; Nishikawa M; Nakano T
    Nihon Rinsho; 1998 Oct; 56(10):2624-9. PubMed ID: 9796329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet reactivity in unstable coronary artery disease.
    Swahn E; Wallentin L
    Thromb Haemost; 1987 Jun; 57(3):302-5. PubMed ID: 2958954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary blood flow volume change is negatively associated with platelet aggregability in patients with non-obstructive ischemic heart disease who have no anti-platelet agents.
    Takae M; Yamamoto E; Fujisue K; Oike F; Nishihara T; Sueta D; Usuku H; Motozato K; Ito M; Hanatani S; Kanazawa H; Arima Y; Takashio S; Nakamura T; Suzuki S; Sakamoto K; Izumiya Y; Soejima H; Kojima S; Yamabe H; Kaikita K; Tsujita K
    Int J Cardiol; 2019 Feb; 277():3-7. PubMed ID: 30173925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention.
    Madan M; Berkowitz SD; Christie DJ; Jennings LK; Smit AC; Sigmon KN; Glazer S; Tcheng JE
    Am Heart J; 2001 Feb; 141(2):226-33. PubMed ID: 11174336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease.
    Jain N; Li X; Adams-Huet B; Sarode R; Toto RD; Banerjee S; Hedayati SS
    Am J Cardiol; 2016 Feb; 117(4):656-663. PubMed ID: 26725101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors.
    Arikan E; Sen S
    Clin Appl Thromb Hemost; 2005 Apr; 11(2):147-59. PubMed ID: 15821821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: the role of antiplatelet therapy.
    Wang TL; Lin JL; Hwang JJ; Tseng CD; Lo HM; Lien WP; Tseng YZ
    Pacing Clin Electrophysiol; 1995 Nov; 18(11):1980-90. PubMed ID: 8552510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.